港交所(00388.HK)將向已接種兩劑疫苗香港員工提供額外兩天年假
港交所(00388.HK)表示,全力支持全球疫苗接種,以應對新型冠狀病毒疫情,將向在香港工作並已接種兩劑新型冠狀病毒疫苗的員工提供額外兩天年假,以肯定他們對社區健康的貢獻和支持香港政府推行的疫苗接種計劃。
港交所集團行政總裁歐冠昇表示,接種疫苗是全球抗疫的最佳方法。港交所的運作對於維護香港作為國際金融中心的地位十分關鍵,集團一直努力確保旗下的市場能在疫情期間維持穩健及有效運作,將繼續竭盡所能,協助香港與全球金融業界盡早回復正常的聯通及交流。
港交所呼籲公司同事和其他能夠接種疫苗的人士盡快接種疫苗,並稱重視員工的健康和安全,會繼續密切留意事態發展,必要時將重新審視相關安排。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.